BeStock  
Stocks › Biotechnology › ONC

BeiGene ONC

US equityMarket cap rank #365Biotechnology
$362.25 −$3.69 (-1.01%)
Market open · Oct 1, 11:50 am ET · After hours $365.94 0.00%
Open$367.94
Prev close$365.94
Day range$361.63 – $371.02
Volume106.7K
Market cap$41.19B
P/E (TTM)64.1
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$1.71B+29.6% YoY
Operating profit$325.05M+269.9% YoY
Net profit$237.01M+151.3% YoY
Diluted EPS$2.08+166.7% YoY
Free cash flow$414.83M+107.6% YoY
Operating cash flow$462.82M

Revenue, last 8 quarters

$1.0BSep '24$1.1BDec '24$1.1BMar '25$1.3BJun '25$1.4BSep '25$1.5BDec '25$1.5BMar '26$1.7BJun '26

Net profit, last 8 quarters

$-121.4MSep '24$-151.9MDec '24$1.3MMar '25$94.3MJun '25$124.8MSep '25$66.5MDec '25$227.4MMar '26$237.0MJun '26

Diluted EPS by quarter

-1.17Sep '24-1.43Dec '240.00Mar '250.78Jun '251.04Sep '250.52Dec '251.95Mar '262.08Jun '26

Free cash flow by quarter

$54.7MSep '24$-17.3MDec '24$-72.3MMar '25$199.8MJun '25$353.8MSep '25$379.8MDec '25$160.5MMar '26$414.8MJun '26

Annual revenue

$308.9MFY20$1.2BFY21$1.4BFY22$2.5BFY23$3.8BFY24$5.3BFY25

Profitability & balance sheet

Gross margin88.9%
Operating margin15.1%
Net margin10.7%
Return on equity14.7%
Return on assets8.5%
Return on invested capital12.0%
Current ratio3.40
Liabilities / assets43.6%
Cash & investments$5.10B
Total debt$1.12B
Net cash (debt)$3.98B
Free cash flow / sales21.4%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $1.71B $1.51B $5.34B $1.50B $1.41B
Total Operating Revenue $1.71B $1.51B $5.34B $1.50B $1.41B
Cost of Revenue $174.53M $167.22M $668.54M $142.42M $196.51M
Gross Profit $1.53B $1.35B $4.67B $1.36B $1.22B
Operating Expense $1.21B $1.10B $4.23B $1.17B $1.05B
Selling and Admin Expenses $593.21M $555.10M $2.08B $555.29M $529.00M
Research & Development $612.28M $541.22M $2.15B $615.42M $523.66M
Operating Profit $325.05M $249.90M $447.14M $185.04M $163.11M
Net Non-Operating Interest Income (Expense) -$11.84M -$5.22M $12.27M -$103,000.00 $3.03M
Non-Operating Interest Income $27.90M $27.66M $70.51M $58.13M $3.03M
Non-Operating Interest Expense $39.74M $32.89M $58.23M – –
Other Income (Expense) -$749,000.00 $14.54M -$42.55M -$35.69M -$18.98M
Other Non-Operating Income (Expenses) -$749,000.00 $14.54M -$42.55M -$35.69M -$18.98M
Pretax Profit $312.46M $259.22M $416.85M $149.24M $147.16M
Tax $75.45M $31.86M $129.92M $82.74M $22.32M
Net Profit $237.01M $227.36M $286.93M $66.50M $124.84M
Profit from Continuing Operations $237.01M $227.36M $286.93M $66.50M $124.84M
Net Income to Parent Company $237.01M $227.36M $286.93M $66.50M $124.84M
Net Income to Common Stockholders $237.01M $227.36M $286.93M $66.50M $124.84M
Basic EPS $2.08 $2.08 $2.60 $0.65 $1.17
Diluted EPS $2.08 $1.95 $2.47 $0.52 $1.04

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $9.18B $8.55B $8.19B $8.19B $7.63B
Total Current Assets $7.22B $6.60B $6.23B $6.23B $5.66B
Cash and Cash Equivalents & Short-Term Investments $5.10B $4.79B $4.55B $4.55B $4.04B
-Cash and Cash Equivalents $5.10B $4.79B $4.55B $4.55B $4.04B
Receivables $1.07B $948.36M $886.86M $886.86M $902.38M
-Accounts Receivable $1.06B $938.02M $865.08M $865.08M $863.28M
-Other Receivables $14.78M $10.35M $21.78M $21.78M $39.10M
Prepaid Assets $106.21M $93.59M $130.73M $130.73M $114.98M
Inventory $732.60M $681.59M $608.23M $608.23M $531.69M
Restricted Cash $161.05M $40.84M $41.28M $41.28M $52.99M
Other Current Assets $46.95M $45.23M $18.96M $18.96M $25.58M
Total Non-Current Assets $1.96B $1.95B $1.95B $1.95B $1.97B
Net PPE $1.79B $1.79B $1.72B $1.72B $1.77B
-Gross PPE $2.41B $2.36B $2.24B $2.24B $2.26B
-Accumulated Depreciation -$619.77M -$573.76M -$528.70M -$528.70M -$485.50M
Investments and Advances $66.06M $65.99M $61.68M $61.68M $100.65M
Non-Current Prepaid Assets $4.60M $4.48M $4.47M $4.47M $4.32M
Goodwill and Other Intangible Assets $60.96M $61.68M $141.58M $141.58M $63.58M
-Other Intangible Assets $60.96M $61.68M $141.58M $141.58M $63.58M
Other Non-Current Assets $34.31M $31.49M $31.30M $31.30M $28.67M
Total Liabilities $4.00B $3.79B $3.83B $3.83B $3.50B
Total Current Liabilities $2.12B $1.81B $1.83B $1.83B $2.37B
Payables $736.21M $612.23M $614.58M $614.58M $496.07M
-Accounts Payable $470.30M $423.55M $479.04M $479.04M $383.68M
-Total Tax Payable $225.70M $144.43M $101.98M $101.98M $91.01M
-Other Payable $40.22M $44.26M $33.56M $33.56M $21.38M
Current Accrued Expenses $827.35M $797.19M $710.14M $710.14M $666.19M
Short-Term Debt and Capital Lease Obligation $212.85M $136.72M $77.99M $77.99M $829.03M
-Current Debt $190.90M $116.14M $57.29M $57.29M $813.30M
-Current Capital Lease Obligation $21.95M $20.58M $20.70M $20.70M $15.73M
Other Current Liabilities $95.46M $108.44M $121.06M $121.06M $142.84M
Total Non-Current Liabilities $1.88B $1.98B $2.00B $2.00B $1.13B
Long Term Debt and Capital Lease Obligation $930.36M $1.01B $1.01B $1.01B $190.96M
-Long Term Debt $882.16M $962.52M $961.91M $961.91M $139.57M
-Long Term Capital Lease Obligation $48.20M $49.67M $52.94M $52.94M $51.39M
Non-Current Liabilities $3.75M $3.61M $3.57M $3.57M $3.60M
Non-Current Deferred Liabilities $85.84M $84.59M $82.19M $82.19M $76.17M
Employee Benefits $17.76M $18.26M $18.17M $18.17M $17.04M
Other Non-Current Liabilities $844.71M $863.02M $879.77M $879.77M $847.07M
Total Equity $5.17B $4.76B $4.36B $4.36B $4.13B
Stockholders' Equity $5.17B $4.76B $4.36B $4.36B $4.13B
Capital Stock $147,000.00 $144,000.00 $144,000.00 $144,000.00 $144,000.00
-Common Stock $147,000.00 $144,000.00 $144,000.00 $144,000.00 $144,000.00
Additional Paid-In Capital $13.05B $12.91B $12.76B $12.76B $12.62B
Retained Earnings -$7.86B -$8.09B -$8.32B -$8.32B -$8.39B
Gains/Losses Not Affecting Retained Earnings -$25.37M -$53.48M -$78.18M -$78.18M -$101.26M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $462.82M $201.34M $1.13B $417.35M $402.55M
Net cash flow from continuing operations $462.82M $201.34M $1.13B $417.35M $402.55M
Net Income from Continuing Operations $237.01M $227.36M $286.93M $66.50M $124.84M
Depreciation & Depletion & Amortization $40.52M $41.14M $141.69M $35.98M $37.28M
Other Non-Cash Items -$21.86M -$1.38M -$88.49M -$23.93M -$34.62M
Change in Working Capital $69.75M -$189.14M $190.90M $163.55M $100.02M
-Change in Receivables -$117.58M -$75.30M -$164.95M $2.34M -$93.93M
-Change in Inventory -$47.15M -$71.84M -$93.17M -$70.51M -$28.84M
-Change in Payables and Accrued Expense $249.97M -$59.01M $391.60M $233.09M $118.73M
-Change in Other Current Assets -$11.38M $15.27M $37.16M -$18.08M $100.56M
-Change in Other Current Liabilities -$4.11M $1.73M $18.97M $15.42M $3.49M
Net cash flow from investing -$49.35M -$45.51M -$276.16M -$38.34M -$49.27M
Net Cash Flow from Continuing Investing Activities -$49.35M -$45.51M -$276.16M -$38.34M -$49.27M
Net PPE Purchase and Sale -$27.48M -$40.79M -$185.84M -$37.52M -$48.08M
Net Intangibles Purchase and Sale -$20.52M $0.00 -$80.69M $0.00 -$691,000.00
Net Investment Purchase and Sale $5.85M $27,000.00 -$8.39M -$10.19M $0.00
Net Other Investing Changes -$7.20M -$4.75M -$1.24M $9.38M -$499,000.00
Financing Cash Flow -$6.05M $68.63M $1.06B $96.93M $961.27M
Net Cash Flow from Continuing Financing Activities -$6.05M $68.63M $1.06B $96.93M $961.27M
Net Issuance Payments Of Debt -$17.05M $50.56M $3.80M $79.12M -$4.26M
Proceeds from Stock Option Exercised $11.05M $23.88M $196.28M $19.24M $80.54M
Net Other Financing Charges -$50,000.00 -$5.81M $859.37M -$1.44M $885.00M
Ending Cash Balance $5.28B $4.85B $4.61B $4.61B $4.11B
Net Change in Cash $407.41M $224.46M $1.91B $475.94M $1.31B
Beginning Cash Balance $4.85B $4.61B $2.64B $4.11B $2.79B
Effect of Exchange Rate Changes $19.84M $19.32M $60.02M $23.16M $9.91M
Free Cash Flow $414.83M $160.55M $861.05M $379.83M $353.78M
Gain/Loss from Continuing Operations – – $596,000.00 – –
Deferred Tax – – $9.47M – –
-Change In Other Working Capital – – $1.29M – –

Discussion

No comments yet — be the first to weigh in on ONC.

Leave a comment

Scroll to Top